Results 121 to 130 of about 23,963 (194)

Pediatric-Onset Multiple Sclerosis at Age 10 Following Nephrotic Syndrome: Early Recognition and Successful Treatment With Fingolimod. [PDF]

Cureus
Mezdaoui I, Mouaddine K, Nahi C, Chkirate B.   +3 more
europepmc   +1 more source

Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis. [PDF]

Front Immunol
Zhao Y, Chen B, Zhao X, Yang R, He W, Li D, Sun Q, Zhang J, Liu X.   +8 more
europepmc   +1 more source

Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study. [PDF]

Front Neurol
Huygens S, Versteegh M, Berg-Hansen P, Bjelland SH, Holmøy T, Torkildsen Ø.   +5 more
europepmc   +1 more source

Case Report: Hemorrhagic Vasculitis in a Patient With Multiple Sclerosis Receiving Fingolimod. [PDF]

Clin Case Rep
Zeynali Esfahani F, Payere M, Karimikhoshnoudian B, Baghaei M, Nahayati M.   +4 more
europepmc   +1 more source

Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks [PDF]

, 2018
Dong, Qunming, Hendin, Barry, Huang, Deren, Jhaveri, Mehul, Jones, Daniel L, Livingston, Terrie, Naismith, Robert T, Watson, Crystal, Wray, Sibyl E   +8 more
core   +1 more source

Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]

Neurol Neuroimmunol Neuroinflamm
Torkildsen Ø, Bru ANS, Behzadi GIN, Myhr KM.   +3 more
europepmc   +1 more source

Differential effect of Fingolimod and Natalizumab treatments on B lymphocyte subpopulations and humoral responses in patients with relapsing remitting multiple sclerosis [PDF]

, 2014
Μπουλογιάννη, Ιουλία
core  

A novel therapeutic approach to adrenocortical carcinoma repurposing fingolimod to target sphingolipid metabolism in metastatic disease. [PDF]

Surgery
Subramanian C, McNamara K, Hess D, Croslow SW, Tan Y, Kiseljak-Vassiliades K, Wierman ME, Sweedler JV, Cohen MS.   +8 more
europepmc   +1 more source

Fingolimod as a Neuroprotective Agent in Ischemic Stroke: A Review of Preclinical and Clinical Evidence. [PDF]

J Clin Med
Ciubotaru A, Covali R, Grosu C, Alexa D, Pilă EF, Cucu AI, Bobu AM, Sargu GD, Riscanu L, Tirnovanu MC, Adam C, Popa R, Filip C, Ignat EB.   +13 more
europepmc   +1 more source

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis. [PDF]

J Neurol Neurosurg Psychiatry
Gavoille A, Nourredine M, Rollot F, Casey R, Mathey G, Kerbrat A, Ciron J, De Sèze J, Stankoff B, Maillart E, Ruet A, Labauge P, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov M, Hankiewicz K, Pottier C, Dos Santos A, Manchon E, Tchikviladze M, Rabilloud M, Subtil F, Vukusic S.   +40 more
europepmc   +1 more source